跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOLUCOMBI TABLET 40MG/12.5MG - HSA Drug Approval Details
Approvals
/
HSA
/
TOLUCOMBI TABLET 40MG/12.5MG
Approved
THERAPEUTIC
TOLUCOMBI TABLET 40MG/12.5MG
KRKA, D.D., NOVO MESTO (SLOVENIA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 24, 2019
Approval ID
db05dba45bcd556b
Company
KRKA, D.D., NOVO MESTO (SLOVENIA)
Type
Therapeutic
Approval Details
Approval Id
db05dba45bcd556b
Drug Name
TOLUCOMBI TABLET 40MG/12.5MG
Product Name
TOLUCOMBI TABLET 40MG/12.5MG
Approval Number
SIN15617P
Approval Date
2019-01-24
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09DA07
Atc Item Name
telmisartan and diuretics
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
Hydrochlorothiazide
12.50mg
Telmisartan
40.00mg
HYDROCHLOROTHIAZIDE
12.5 MG
TELMISARTAN
40 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 24, 2019
Approval ID
db05dba45bcd556b
Type
Therapeutic
Back to HSA Approvals